Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferri, C.
Right arrow Articles by De Mattia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferri, C.
Right arrow Articles by De Mattia, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 4 431-436, Copyright © 1995 by American Diabetes Association


ARTICLES

Plasma endothelin-1 levels in obese hypertensive and normotensive men

C Ferri, C Bellini, G Desideri, L Di Francesco, R Baldoncini, A Santucci and G De Mattia
University La Sapienza, Institute of I Clinica Medica, Rome, Italy.

Plasma endothelin-1 (ET-1) levels were studied in 15 obese hypertensive (mean age 48.5 +/- 3.9 years) and 15 obese normotensive men (mean age 49.5 +/- 3.6 years) before and after weight loss due to an 800 kcal/day diet lasting 12 weeks. Circulating peptide concentrations were also assessed in nonobese hypertensive (n = 11) and normotensive men (n = 12). Baseline plasma ET-1 levels were similar in obese hypertensive (0.87 +/- 0.22 pg/ml) and obese normotensive men (0.91 +/- 0.30 pg/ml). In seven obese hypertensive men, caloric restriction normalized blood pressure levels (systolic: from 166.6 +/- 8.1 to 145.0 +/- 6.3 mmHg, P < 0.0001; diastolic: from 106.6 +/- 5.1 to 89.1 +/- 2.0 mmHg, P < 0.0001) and decreased body mass index (BMI) (from 33.4 +/- 1.6 to 29.6 +/- 2.1 kg/m2, P < 0.002) and plasma ET-1 levels (from 0.93 +/- 0.21 to 0.64 +/- 0.26 pg/ml, P < 0.05). In the remaining obese hypertensive men (n = 8), blood pressure levels were not normalized by caloric restriction despite a significant decrease of BMI and plasma ET-1 levels (from 0.83 +/- 0.23 to 0.60 +/- 0.16 pg/ml, P < 0.04). Weight loss also significantly decreased BMI and ET-1 (from 0.91 +/- 0.30 to 0.65 +/- 0.19 pg/ml, P < 0.01) in obese normotensive men. Baseline ET-1 and fasting insulin levels were significantly correlated in obese hypertensive (r = 0.518, P < 0.05) and obese normotensive men (r = 0.535, P < 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
C.-C. Juan, T.-Y. Chuang, C.-L. Chang, S.-W. Huang, and L.-T. Ho
Endothelin-1 Regulates Adiponectin Gene Expression and Secretion in 3T3-L1 Adipocytes via Distinct Signaling Pathways
Endocrinology, April 1, 2007; 148(4): 1835 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow
Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease
Diabetes Care, March 1, 2007; 30(3): 591 - 596.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Silver, S. D. Beske, D. D. Christou, A. J. Donato, K. L. Moreau, I. Eskurza, P. E. Gates, and D. R. Seals
Overweight and Obese Humans Demonstrate Increased Vascular Endothelial NAD(P)H Oxidase-p47phox Expression and Evidence of Endothelial Oxidative Stress
Circulation, February 6, 2007; 115(5): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P.-L. Tharaux, I. Hagege, S. Placier, M. Vayssairat, A. Kanfer, R. Girot, and J.-C. Dussaule
Urinary endothelin-1 as a marker of renal damage in sickle cell disease
Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2408 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Usui, T. Imamura, J. L. Babendure, H. Satoh, J.-C. Lu, C. J. Hupfeld, and J. M. Olefsky
G Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both G{alpha}q/11 and Insulin Receptor Substrate-1 Pathways in 3T3-L1 Adipocytes
Mol. Endocrinol., November 1, 2005; 19(11): 2760 - 2768.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. B. Strawbridge and J. S. Elmendorf
Phosphatidylinositol 4,5-Bisphosphate Reverses Endothelin-1-Induced Insulin Resistance via an Actin-Dependent Mechanism
Diabetes, June 1, 2005; 54(6): 1698 - 1705.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C.-C. Juan, C.-L. Chang, Y.-H. Lai, and L.-T. Ho
Endothelin-1 induces lipolysis in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1146 - E1152.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, C Papamichael, A Aessopos, J Lekakis, and M Mavrikakis
Metformin administration improves endothelial function in women with polycystic ovary syndrome
Eur. J. Endocrinol., May 1, 2005; 152(5): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F.-P. Xu, M.-S. Chen, Y.-Z. Wang, Q. Yi, S.-B. Lin, A. F. Chen, and J.-D. Luo
Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Circulation, September 7, 2004; 110(10): 1269 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, T. Russo, D. Labella, F. Zullo, G. Lombardi, and A. Colao
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4588 - 4593.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, and J. S. Tapanainen
Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4649 - 4654.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. A. Treiber, P. Barbeau, G. Harshfield, H.-S. Kang, D. M. Pollock, J. S. Pollock, and H. Snieder
Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity
Hypertension, October 1, 2003; 42(4): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Jin, J. Nakura, Z. Wu, M. Yamamoto, M. Abe, Y. Tabara, Y. Yamamoto, M. Igase, K. Kohara, and T. Miki
Association of Endothelin-1 Gene Variant With Hypertension
Hypertension, January 1, 2003; 41(1): 163 - 167.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. J. Mather, B. Mirzamohammadi, A. Lteif, H. O. Steinberg, and A. D. Baron
Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes
Diabetes, December 1, 2002; 51(12): 3517 - 3523.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res., April 5, 2002; 90(6): 711 - 718.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Asai, T. Ohkubo, T. Katsuya, J. Higaki, Y. Fu, M. Fukuda, A. Hozawa, M. Matsubara, H. Kitaoka, I. Tsuji, et al.
Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study
Hypertension, December 1, 2001; 38(6): 1321 - 1324.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, G. Spina, C. Kouli, and I. Migdalis
Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4666 - 4673.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
R.J. Irving, J.P. Noon, G.C.M. Watt, D.J. Webb, and B.R. Walker
Activation of the endothelin system in insulin resistance
QJM, June 1, 2001; 94(6): 321 - 326.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K.-i. Ishibashi, T. Imamura, P. M. Sharma, S. Ugi, and J. M. Olefsky
The Acute and Chronic Stimulatory Effects of Endothelin-1 on Glucose Transport Are Mediated by Distinct Pathways in 3T3-L1 Adipocytes
Endocrinology, December 1, 2000; 141(12): 4623 - 4628.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Ferri, G. Desideri, M. Valenti, C. Bellini, M. Pasin, A. Santucci, and Giancarlo De Mattia
Early Upregulation of Endothelial Adhesion Molecules in Obese Hypertensive Men
Hypertension, October 1, 1999; 34(4): 568 - 573.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Tiret, O. Poirier, V. Hallet, T. A. McDonagh, C. Morrison, J. J. V. McMurray, H. J. Dargie, D. Arveiler, J.-B. Ruidavets, G. Luc, et al.
The Lys198Asn Polymorphism in the Endothelin-1 Gene Is Associated With Blood Pressure in Overweight People
Hypertension, May 1, 1999; 33(5): 1169 - 1174.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Ferri, C. Bellini, G. Desideri, E. Giuliani, L. De Siati, S. Cicogna, and A. Santucci
Clustering of Endothelial Markers of Vascular Damage in Human Salt-Sensitive Hypertension : Influence of Dietary Sodium Load and Depletion
Hypertension, November 1, 1998; 32(5): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Thorin, P. Cernacek, and J. Dupuis
Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia
Hypertension, April 1, 1998; 31(4): 1035 - 1041.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Scherrer and C. Sartori
Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity
Circulation, December 2, 1997; 96(11): 4104 - 4113.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. K. Krowicki, N. A. Nathan, and P. J. Hornby
Excitatory Gastric Motor and Cardiovascular Effects of Endothelins in the Dorsal Vagal Complex are Mediated Through ETA Receptors
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 535 - 542.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res., April 5, 2002; 90(6): 711 - 718.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.